A detailed history of Consilium Wealth Advisory, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Consilium Wealth Advisory, LLC holds 6,279 shares of BSX stock, worth $525,049. This represents 0.29% of its overall portfolio holdings.

Number of Shares
6,279
Previous 6,016 4.37%
Holding current value
$525,049
Previous $463,000 13.61%
% of portfolio
0.29%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$72.96 - $84.0 $19,188 - $22,092
263 Added 4.37%
6,279 $526,000
Q2 2024

Aug 01, 2024

BUY
$67.33 - $77.71 $405,057 - $467,503
6,016 New
6,016 $463,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Consilium Wealth Advisory, LLC Portfolio

Follow Consilium Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consilium Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consilium Wealth Advisory, LLC with notifications on news.